These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6186225)

  • 21. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants.
    Butchaiah G; Morgan DO
    Virus Res; 1997 Dec; 52(2):183-94. PubMed ID: 9495534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles.
    Harmsen MM; Fijten HP; Westra DF; Coco-Martin JM
    Vaccine; 2011 Mar; 29(15):2682-90. PubMed ID: 21316500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic sites on foot-and-mouth disease virus type A10.
    Thomas AA; Woortmeijer RJ; Puijk W; Barteling SJ
    J Virol; 1988 Aug; 62(8):2782-9. PubMed ID: 2455819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foot-and-mouth disease virus C3 Resende subtype analysed by means of competition RIA using neutralizing monoclonal antibodies.
    Valcic MA; Panjevic DJ
    Zentralbl Veterinarmed B; 1992 May; 39(3):193-200. PubMed ID: 1379398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle.
    Cartwright B; Chapman WG; Sharpe RT
    Res Vet Sci; 1982 May; 32(3):338-42. PubMed ID: 6179141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of liquid-phase and Mab-blocking ELISA for assessment of the reactivity of monoclonal antibodies to foot-and-mouth disease virus.
    Pattnaik B; Venkataramanan R
    J Immunol Methods; 1994 Jun; 172(2):265-7. PubMed ID: 8034975
    [No Abstract]   [Full Text] [Related]  

  • 30. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Butchaiah G; Rao BU
    Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
    Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi RD; Little SP; Gale C
    Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains.
    Rana SK; Bagchi T
    Vet Immunol Immunopathol; 2008 Apr; 122(3-4):241-9. PubMed ID: 18291535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct single-step surface plasmon resonance analysis of interactions between small peptides and immobilized monoclonal antibodies.
    Gomes P; Giralt E; Andreu D
    J Immunol Methods; 2000 Feb; 235(1-2):101-11. PubMed ID: 10675762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of anti-idiotypic antibodies generated against foot-and-mouth disease virus neutralizing monoclonal antibodies.
    Baxt B; Garmendia AE; Morgan DO
    Viral Immunol; 1989; 2(2):103-13. PubMed ID: 2550021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.
    Stave JW; Card JL; Morgan DO; Vakharia VN
    Virology; 1988 Jan; 162(1):21-9. PubMed ID: 2827379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.